Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.87 is 72% below its 5-year average of 6.66, near the low end of its 5-year range (1.69–12.79).
As of the fiscal period ended Tuesday, June 30, 2026. 8.71% below its 12-month average of 2.05.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.87.
QUICK RATIO (ACID-TEST)
1.87
QUICK RATIO (ACID-TEST) AVG TTM
2.05
QUICK RATIO (ACID-TEST) AVG 3Y
5.35
QUICK RATIO (ACID-TEST) AVG 5Y
6.66
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-8.71%
CURRENT VS 3Y AVG
-64.94%
CURRENT VS 5Y AVG
-71.87%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
-44.06%
vs the sector median at left
Phathom Pharmaceuticals, Inc.
Market Cap
$548.51M
Quick Ratio (Acid-Test)
1.87
TTM Avg
2.05
3Y Avg
5.35
5Y Avg
6.66
Market Cap
$557.32M
Quick Ratio (Acid-Test)
9.36
TTM Avg
2.17
3Y Avg
1.76
5Y Avg
2.63
Market Cap
$560.00M
Quick Ratio (Acid-Test)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$538.01M
Quick Ratio (Acid-Test)
8.36
TTM Avg
10.03
3Y Avg
20.35
5Y Avg
14.11
Market Cap
$529.58M
Quick Ratio (Acid-Test)
27.59
TTM Avg
10.29
3Y Avg
10.12
5Y Avg
12.12
Market Cap
$533.04M
Quick Ratio (Acid-Test)
33.56
TTM Avg
31.41
3Y Avg
17.80
5Y Avg
16.41
Market Cap
$531.98M
Quick Ratio (Acid-Test)
8.95
TTM Avg
10.43
3Y Avg
5.97
5Y Avg
5.34
Market Cap
$531.52M
Quick Ratio (Acid-Test)
1.68
TTM Avg
2.23
3Y Avg
2.63
5Y Avg
2.59
Market Cap
$571.13M
Quick Ratio (Acid-Test)
2.36
TTM Avg
2.55
3Y Avg
5.33
5Y Avg
7.55
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Phathom Pharmaceuticals, Inc. (PHAT) | $548.51M | 1.87 | 2.05 | 5.35 | 6.66 |
| CytomX Therapeutics, Inc. (CTMX)vs › | $557.32M | 9.36 | 2.17 | 1.76 | 2.63 |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A | N/A | N/A | N/A |
| ProKidney Corp. (PROK)vs › | $538.01M | 8.36 | 10.03 | 20.35 | 14.11 |
| Shattuck Labs, Inc. (STTK)vs › | $529.58M | 27.59 | 10.29 | 10.12 | 12.12 |
| Monopar Therapeutics Inc. (MNPR)vs › | $533.04M | 33.56 | 31.41 | 17.80 | 16.41 |
| Delcath Systems, Inc. (DCTH)vs › | $531.98M | 8.95 | 10.43 | 5.97 | 5.34 |
| Nuvectis Pharma, Inc. (NVCT)vs › | $531.52M | 1.68 | 2.23 | 2.63 | 2.59 |
| CorMedix Inc. (CRMD)vs › | $571.13M | 2.36 | 2.55 | 5.33 | 7.55 |
| Immix Biopharma, Inc. (IMMX)vs › | $524.43M | 25.13 | 6.17 | 7.34 | 19.91 |
Quick Ratio
1.87
Excludes inventory
Current Ratio
1.92
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.87 |
| 2026-03-31 | 2.16 |
| 2025-12-31 | 1.69 |
| 2025-09-30 | 2.19 |
| 2025-06-30 | 2.35 |
| 2025-03-31 | 3.54 |
| 2024-12-31 | 4.16 |
| 2024-09-30 | 5.68 |
| 2024-06-30 | 6.44 |
| 2024-03-31 | 7.80 |
| 2023-12-31 | 10.22 |
| 2023-09-30 | 9.45 |
| 2023-06-30 | 11.96 |
| 2023-03-31 | 9.68 |
| 2022-12-31 | 6.12 |
| 2022-09-30 | 8.60 |
| 2022-06-30 | 9.93 |
| 2022-03-31 | 12.79 |
| 2021-12-31 | 9.86 |
| 2021-09-30 | 8.10 |
| 2021-06-30 | 5.34 |
| 2021-03-31 | 5.94 |
| 2020-12-31 | 5.25 |
| 2020-09-30 | 8.21 |
| 2020-06-30 | 18.76 |
| 2020-03-31 | 57.22 |
| 2019-12-31 | 68.20 |
| 2019-09-30 | 0.37 |
| 2019-06-30 | 0.58 |
| 2019-03-31 | 0.00 |
| 2018-12-31 | 0.42 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
